| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 22.624 | 56.382 | 76.953 | 91.174 | 102.899 | 103.863 | 109.365 | 117.273 | 123.229 |
| Total Income - EUR | - | 22.624 | 56.383 | 76.954 | 91.175 | 102.900 | 103.864 | 109.366 | 117.275 | 123.231 |
| Total Expenses - EUR | - | 9.727 | 28.127 | 37.816 | 38.487 | 48.080 | 48.117 | 47.585 | 44.829 | 46.960 |
| Gross Profit/Loss - EUR | - | 12.898 | 28.256 | 39.138 | 52.688 | 54.820 | 55.747 | 61.781 | 72.446 | 76.271 |
| Net Profit/Loss - EUR | - | 12.672 | 27.692 | 38.368 | 51.776 | 53.840 | 54.708 | 60.688 | 71.273 | 72.574 |
| Employees | - | 4 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 |
Check the financial reports for the company - Olarusanmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 330 | 325 | 319 | 984 | 1.316 | 1.038 | 895 | 892 | 887 |
| Current Assets | - | 14.269 | 40.851 | 65.642 | 88.614 | 107.658 | 105.300 | 111.363 | 73.223 | 77.277 |
| Inventories | - | 98 | 0 | 0 | 633 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.254 | 4.533 | 6.147 | 7.864 | 9.021 | 8.192 | 12.799 | 67.542 | 65.924 |
| Cash | - | 11.917 | 36.318 | 59.495 | 80.117 | 98.637 | 97.108 | 98.564 | 5.681 | 11.353 |
| Shareholders Funds | - | 12.716 | 27.744 | 38.420 | 51.827 | 53.890 | 54.757 | 60.736 | 71.322 | 72.622 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.883 | 13.431 | 27.540 | 37.772 | 55.084 | 51.581 | 51.522 | 2.793 | 5.542 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Olarusanmed Srl